Tag: Business

Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...

MAPLE GROVE, Minn. - On a fateful day in New York City, the world lost Brian Thompson, the esteemed CEO of UnitedHealthcare. Thompson's journey from a small town in Iowa to the pinnacle of...

Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs to be passed by Congress by December to avoid obstacles,...

Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA sequence changes like insertions, substitutions, or deletions, among others. Common...

Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia. The drug, ziftomenib, is currently in a late-stage clinical trial...

Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless has launched a new biotech company called Jupiter. Here's what you...

Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...

In the world of corporate movements and trends, it's always exciting to hear about new hires, promotions, and other changes within companies. If you have any news to share about someone new joining your...

23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...

Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry. This move by GSK marks a significant setback for the...

Adam: Hey Matt, glad you could join me today. The future of the biotech industry post-Trump presidency is something that many are curious about. One key aspect that everyone is keeping an eye on...

Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in an antitrust investigation against Sutter Health in the past, Thomas...